Active Covid-19 caseload comes down to 29,268 in Tamil Nadu

▴ Active Covid-19 caseload comes down to 29,268 in Tamil Nadu
In Tamil Nadu, the active Covid-19 caseload has come down to 29,268.

In Tamil Nadu, the active Covid-19 caseload has come down to 29,268. The new infections in the last 24-hours have also dropped to 2,708.
 
AIR correspondent reports, the number of people tested for the SARSCoV2 virus in Tamil Nadu have reached more than 93.28 lakh, all using the RT-PCR kits.
 

71 thousand people were tested on a single day on Monday, out of whom, 2708 people were confirmed with the infection.
 
The per-day infection number is almost close to the figure of June 24th.
 
But the difference is that, on June 24th, only about 30-thousand people were tested.
 
The number of tests is crucial in assessing the spread of the virus, as being said by medical experts.

 
The state has 200 laboratories to carry out the tests, including a private lab approved on Monday in Chennai.
 
66 of the labs are in government hospitals, where the tests are being done freely.
 
The state health department has warned the private labs of severe actions if the people are charged more fee than what is approved.

Tags : #tamilnadu #covid19cases #rtpcrkits #chennai #recoveryrate

About the Author


Rohit Sharma

Writer, Health Enthusiast, and an Accountant, Rohit Sharma is a writer at medicircle, penning down his thoughts about healthcare research, innovations, trends in healthcare and simply all about healthcare. Write to rohit on [email protected]

Related Stories

Loading Please wait...
-Advertisements-


Trending Now

Covid technical Advisory panel advises Karnataka health dept to be prepared for 2nd wave of COVID-19 pandemicDecember 04, 2020
Telangana reports 631 fresh cases of COVID-19December 04, 2020
Odisha crosses milestone in conducting over 6 million tests for COVID-19December 04, 2020
New Phase 3 Data Show TAK-620 (maribavir), an Investigational Drug for the Treatment of Transplant Recipients with Refractory/Resistant Cytomegalovirus (CMV) Infections, Meets Primary EndpointDecember 04, 2020
Shape Therapeutics Unveils AAVid™ Capsid Discovery Platform and Identification of Novel Tissue-Specific AAV Variants, Solving a Fundamental Delivery Challenge in Gene TherapyDecember 04, 2020
ReAlta Life Sciences Announces EMA Orphan Drug Designation for RLS-0071 for the Treatment of Neonatal EncephalopathyDecember 04, 2020
I2O Therapeutics receives strategic investment from Colorcon VenturesDecember 04, 2020
Study shows personalized provider navigation using machine intelligence may reduce post-surgical hospitalizations and lower costsDecember 04, 2020
Zydus receives approval from DCGI to commence Phase III clinical trials with Pegylated Interferon alpha-2b in India December 04, 2020
PharmaEngine, Inc. collaborates with Sentinel Oncology for SOL-578, a Chk1 inhibitorDecember 04, 2020
Rhizen Pharmaceuticals Announces US FDA Acceptance of its IND ApplicationDecember 04, 2020
1450 new cases of COVID-19 reported in Madhya PradeshDecember 04, 2020
COVID-19 recovery rate in country improves to 94.20 pctDecember 04, 2020
Over 11,70,000 samples tested for COVID-19 across country in last 24 hoursDecember 04, 2020
Britain to cover COVID-19 vaccine side-effects under damages schemeDecember 04, 2020
India’s Active Caseload further dips to 4.35% of Total CasesDecember 04, 2020
COVID-19 recovery rate in Bihar improves to 97.12 pctDecember 04, 2020
Gujarat records 1540 new cases of COVID-19December 04, 2020
Catalyst Biosciences receives FDA Fast track designation for subcutaneous MarzAADecember 04, 2020
AbbVie and Frontier Medicines establish global partnership for research and developmentDecember 04, 2020